MMP9 displays substrate specificity for type-IV collagen and FN; it promotes epithelial-mesenchymal transition (EMT) by cleaving FN, thus enabling the release of transforming growth factor-β (TGF-β) and promoting tumor growth [24]. This evidence concerns the gene FN1 and neoplasm.